Mason Crossman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mason Crossman has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Stephen Bacchi
Faculty of Health and Medical Sciences, Adelaide University, Adelaide, Australia
4 shared publicationsWeng Onn Chan
Faculty of Health and Medical Sciences, Adelaide University, Adelaide, Australia
3 shared publicationsBenjamin Cook
2 shared publicationsBrandon Stretton
Adelaide Medical School, The University of Adelaide Adelaide South Australia Australia
2 shared publicationsChristina Gao
2 shared publicationsHaelynn Gim
2 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Wiley in JEADV Clinical Practice
Subcorneal Pustular Dermatosis, a Systematic Review and Pooled Analysis of a Rare and Underdiagnosed Disease
Background: Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives: To summarise the demographic, clinical, histopathological, management and disease course of SPD. Methods: A systematic review was conducted following PRISMA guidelines including all peer‐reviewed, English‐language studies reporting one or more SPD cases. Results: A total of 169 studies (17 case series, 152 case reports) and 205 patients were identified. The median age at diagnosis was 50 years, with a female‐to‐male ratio of 1.77:1. Over two‐thirds of patients had no comorbidities. Monoclonal gammopathy of unknown significance (MGUS) was the most common comorbidity (9.8%), followed by connective tissue disease (7.3%). Clinical pustules were observed in 92.3% of patients, most commonly affecting the trunk (75.1%), limbs (62%), axilla (44.4%) and groin (36.1%). Pruritus was the most common symptom (44.9%), with pain, burning, or irritation occurring in 16.3%. The median time to diagnosis in cases presenting with rash only was 3 years. A precipitant was identified in 22.9% of cases, including infections, flare of underlying condition, or medications such as calcium channel blockers, TNF‐α inhibitors, and antibiotics. In patients who had histopathological findings reported, subcorneal pustules and perivascular infiltrate most common. Dapsone was the most frequently used treatment (133/189, 70.4%), achieving complete response in 33.8%. Topical and systemic corticosteroids achieved complete responses in 22.5% and 29.6%, respectively. Biologics, mostly TNF‐α inhibitors, were used in 11.6%, with complete and partial responses in 63.6% and 27.3%. Limitations: The review's findings are limited by a limited sample size of heterogeneous, observational data, which can be prone to publication bias, so conclusions on SPD's clinical features and treatment efficacy should be interpreted cautiously pending larger, controlled studies. Conclusions: SPD remains a diagnostic and therapeutic challenge, with frequent delays and limited effectiveness of current treatments. These findings underscore the urgent need for prospective studies and targeted therapies to improve outcomes in this rare dermatosis. Systematic Review Registration: PROSPERO CRD42022344461.
- 5 October 2026
- Published by Wiley in JEADV Clinical Practice
Open AccessSubcorneal Pustular Dermatosis, a Systematic Review and Pooled Analysis of a Rare and Underdiagnosed Disease
Background: Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives: To summarise the demographic, clinical, histopathological, management and disease course of SPD. Methods: A systematic review was conducted following PRISMA guidelines including all peer‐reviewed, English‐language studies reporting one or more SPD cases. Results: A total of 169 studies (17 case series, 152 case reports) and 205 patients were identified. The median age at diagnosis was 50 years, with a female‐to‐male ratio of 1.77:1. Over two‐thirds of patients had no comorbidities. Monoclonal gammopathy of unknown significance (MGUS) was the most common comorbidity (9.8%), followed by connective tissue disease (7.3%). Clinical pustules were observed in 92.3% of patients, most commonly affecting the trunk (75.1%), limbs (62%), axilla (44.4%) and groin (36.1%). Pruritus was the most common symptom (44.9%), with pain, burning, or irritation occurring in 16.3%. The median time to diagnosis in cases presenting with rash only was 3 years. A precipitant was identified in 22.9% of cases, including infections, flare of underlying condition, or medications such as calcium channel blockers, TNF‐α inhibitors, and antibiotics. In patients who had histopathological findings reported, subcorneal pustules and perivascular infiltrate most common. Dapsone was the most frequently used treatment (133/189, 70.4%), achieving complete response in 33.8%. Topical and systemic corticosteroids achieved complete responses in 22.5% and 29.6%, respectively. Biologics, mostly TNF‐α inhibitors, were used in 11.6%, with complete and partial responses in 63.6% and 27.3%. Limitations: The review's findings are limited by a limited sample size of heterogeneous, observational data, which can be prone to publication bias, so conclusions on SPD's clinical features and treatment efficacy should be interpreted cautiously pending larger, controlled studies. Conclusions: SPD remains a diagnostic and therapeutic challenge, with frequent delays and limited effectiveness of current treatments. These findings underscore the urgent need for prospective studies and targeted therapies to improve outcomes in this rare dermatosis. Systematic Review Registration: PROSPERO CRD42022344461.
- Open Access
- 3 June 2026
- Published by Elsevier in Equity Neuroscience
- Vol. 2 (3)
Challenging medical professionalism cases delivered by artificial intelligence
- 3 June 2026
- Published by Elsevier in Equity Neuroscience
- Vol. 2 (3)
Open AccessChallenging medical professionalism cases delivered by artificial intelligence
- Open Access
- 9 May 2026
- Published by Springer Nature in Eye
- Vol. 40 (10) , 1425-1426
Advertising and large language models: a new frontier influencing medical practice
- 9 May 2026
- Published by Springer Nature in Eye
- Vol. 40 (10) , 1425-1426
Open AccessAdvertising and large language models: a new frontier influencing medical practice
- Open Access
- 6 May 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 196, 112306
When and how to replace a new reference standard for medical tests: a scoping review identifying methodological priorities
- 6 May 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 196, 112306
Open AccessWhen and how to replace a new reference standard for medical tests: a scoping review identifying methodological priorities
- Top Cited PapersOpen Access
- 6 February 2026
- Published by Elsevier in Radiography
- Vol. 32 (3) , 103339
Malpractice in the machine age: Legal and ethical responses to machine learning in medical imaging
- 6 February 2026
- Published by Elsevier in Radiography
- Vol. 32 (3) , 103339
Top Cited PapersOpen AccessMalpractice in the machine age: Legal and ethical responses to machine learning in medical imaging
- Open Access
- 19 January 2026
- Published by Springer Nature in Research Square
External generalisability of detection rates of 18F-FDG-PET for occult malignancy in embolic stroke of undetermined source
Introduction: In embolic stroke of undetermined source (ESUS) 18F-Fluorodeoxyglucose positron emission tomography (18F-FDG-PET) may have a role in detecting several conditions, including malignancies. Currently, there are limited data and no guidelines to inform the use of 18F-FDG-PET in patients with ESUS. This study was conducted with the aim of determining which factors predict a significant abnormality on 18F-FDG-PET in patients with ESUS, to compare with existing literature from other regions. Patients and methods: This cohort study encompassed all public neurology inpatients in South Australia during a two-year period. Patients admitted with ESUS who received an 18F-FDG-PET were included in the study and underwent case note review for clinical, laboratory, and imaging features that may predict significant abnormalities on 18F-FDG-PET. Results: Of 6,786 eligible cases, 36 fulfilled inclusion criteria. In these patients, 8/36 (22.2%) had a significant abnormality on 18F-FDG-PET, all of which were malignancy. These findings informed the stroke aetiology in 7/8 (87.5%) cases. In 7/8 (87.5%) of these cases, the positive 18F-FDG-PET was preceded by alternative imaging evidence of a significant abnormality. The one case without a prior radiological abnormality was due to endometrial cancer. Of those with the three-territory sign, 75% (3/4) had a positive 18F-FDG-PET. Conversely, 90.9% (10/11) of cases with other systemic vascular events had no significant abnormalities on 18F-FDG-PET. Conclusions: In this cohort, nearly all cases with significant abnormalities detected on 18F-FDG-PET in patients with ESUS were preceded by other radiological findings suggestive of a significant abnormality.
- 19 January 2026
- Published by Springer Nature in Research Square
Open AccessExternal generalisability of detection rates of 18F-FDG-PET for occult malignancy in embolic stroke of undetermined source
Introduction: In embolic stroke of undetermined source (ESUS) 18F-Fluorodeoxyglucose positron emission tomography (18F-FDG-PET) may have a role in detecting several conditions, including malignancies. Currently, there are limited data and no guidelines to inform the use of 18F-FDG-PET in patients with ESUS. This study was conducted with the aim of determining which factors predict a significant abnormality on 18F-FDG-PET in patients with ESUS, to compare with existing literature from other regions. Patients and methods: This cohort study encompassed all public neurology inpatients in South Australia during a two-year period. Patients admitted with ESUS who received an 18F-FDG-PET were included in the study and underwent case note review for clinical, laboratory, and imaging features that may predict significant abnormalities on 18F-FDG-PET. Results: Of 6,786 eligible cases, 36 fulfilled inclusion criteria. In these patients, 8/36 (22.2%) had a significant abnormality on 18F-FDG-PET, all of which were malignancy. These findings informed the stroke aetiology in 7/8 (87.5%) cases. In 7/8 (87.5%) of these cases, the positive 18F-FDG-PET was preceded by alternative imaging evidence of a significant abnormality. The one case without a prior radiological abnormality was due to endometrial cancer. Of those with the three-territory sign, 75% (3/4) had a positive 18F-FDG-PET. Conversely, 90.9% (10/11) of cases with other systemic vascular events had no significant abnormalities on 18F-FDG-PET. Conclusions: In this cohort, nearly all cases with significant abnormalities detected on 18F-FDG-PET in patients with ESUS were preceded by other radiological findings suggestive of a significant abnormality.
- Open Access
- 12 December 2025
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 18 (1) , 69-75
Epilepsy Surgery in Drug-Resistant Epilepsy Facilitated by Artificial Intelligence: A Case of Left Temporal Encephalocele
Introduction: Epilepsy surgery remains underutilized despite strong evidence supporting its efficacy for appropriately selected patients with drug-resistant epilepsy (DRE). Case Presentation: We describe the case of a 23-year-old woman with a 4-year history of refractory focal impaired awareness seizures, experiencing up to four episodes per week despite multiple trialed antiseizure medications at tolerated doses. Initial investigations including magnetic resonance imaging (MRI), EEG, and paraneoplastic screening were unremarkable, and she was managed as having non-lesional left temporal lobe epilepsy. As part of an artificial intelligence driven research initiative, a natural language processing based random forest algorithm reviewing neurology clinic documentation identified her as a potential surgical candidate. Complementary large language model analysis supported extraction of relevant seizure and imaging information. This prompted re-evaluation of the case, with PET demonstrating left temporal hypometabolism and repeat MRI revealing a previously unrecognized encephalocele. She subsequently underwent left temporal lobe polectomy with encephalocele disconnection. The procedure was successful, and she has remained seizure-free for 1 year postoperatively, allowing initiation of ASM weaning and the possibility of long-term cure. Conclusion: This case illustrates the transformative potential of epilepsy surgery for individuals with DRE and the promising role of artificial intelligence augmented triage systems in reducing delays to surgical referral. Given the morbidity, mortality, and economic burden associated with DRE, timely surgical evaluation should be considered the standard of care for eligible patients. Integrating artificial intelligence tools into clinical workflows may help overcome longstanding barriers to access and ensure that life-changing interventions are offered earlier in the disease course.
- 12 December 2025
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 18 (1) , 69-75
Open AccessEpilepsy Surgery in Drug-Resistant Epilepsy Facilitated by Artificial Intelligence: A Case of Left Temporal Encephalocele
Introduction: Epilepsy surgery remains underutilized despite strong evidence supporting its efficacy for appropriately selected patients with drug-resistant epilepsy (DRE). Case Presentation: We describe the case of a 23-year-old woman with a 4-year history of refractory focal impaired awareness seizures, experiencing up to four episodes per week despite multiple trialed antiseizure medications at tolerated doses. Initial investigations including magnetic resonance imaging (MRI), EEG, and paraneoplastic screening were unremarkable, and she was managed as having non-lesional left temporal lobe epilepsy. As part of an artificial intelligence driven research initiative, a natural language processing based random forest algorithm reviewing neurology clinic documentation identified her as a potential surgical candidate. Complementary large language model analysis supported extraction of relevant seizure and imaging information. This prompted re-evaluation of the case, with PET demonstrating left temporal hypometabolism and repeat MRI revealing a previously unrecognized encephalocele. She subsequently underwent left temporal lobe polectomy with encephalocele disconnection. The procedure was successful, and she has remained seizure-free for 1 year postoperatively, allowing initiation of ASM weaning and the possibility of long-term cure. Conclusion: This case illustrates the transformative potential of epilepsy surgery for individuals with DRE and the promising role of artificial intelligence augmented triage systems in reducing delays to surgical referral. Given the morbidity, mortality, and economic burden associated with DRE, timely surgical evaluation should be considered the standard of care for eligible patients. Integrating artificial intelligence tools into clinical workflows may help overcome longstanding barriers to access and ensure that life-changing interventions are offered earlier in the disease course.
- 29 November 2025
- Published by Wiley in Internal Medicine Journal
- Vol. 56 (1) , 144-145
Who will review the reviewers? Anonymity and selection processes for peer‐reviewers require evaluation
- 29 November 2025
- Published by Wiley in Internal Medicine Journal
- Vol. 56 (1) , 144-145
Who will review the reviewers? Anonymity and selection processes for peer‐reviewers require evaluation
- 16 September 2025
- Published by CSIRO Publishing in Australian Health Review
- Vol. 49 (5)
Environmental impact of travel to neurosurgery outpatient appointments in South Australia
Objective: Outpatient attendance at metropolitan neurosurgical clinics imposes significant logistical and psychosocial burdens on patients, particularly those with central nervous system tumours residing in geographically dispersed regions. In Australia, where vast distances separate many regional populations from tertiary care centres, these burdens may also translate into substantial environmental costs. This study sought to quantify the environmental and economic impact associated with patient travel to public neurosurgery outpatient services in South Australia. Methods: A retrospective analysis was conducted using administrative data from all in-person public neurosurgery outpatient appointments across South Australia’s two public neurosurgical centres between July 2022 and June 2024. Patient postcode data were used to calculate geodesic one-way travel distances to clinic sites. Estimated fuel consumption, carbon dioxide (CO2) emissions, and petrol costs were derived using published national averages for vehicle efficiency and emissions. Analyses were stratified by Modified Monash Model (MMM) classification to assess regional variation. Results: The cohort comprised 9840 patients, accounting for 19,148 outpatient appointments. The median one-way travel distance was 17.7 km (IQR: 9.4–52.1 km), with 16.9% of patients travelling over 100 km. The cumulative distance travelled was 1.75 million km over 2 years, equating to an estimated petrol consumption of 185,531 L and CO2 emissions of 435.6 tonnes. The associated direct fuel cost exceeded AUD 357,000. Although individual environmental impact increased with MMM classification, the highest aggregate emissions were attributable to patients in MMM category 5, reflecting both travel distance and patient volume. Conclusions: The environmental and financial burdens associated with outpatient neurosurgical care are considerable, particularly for patients in rural and remote areas. These findings underscore the need to explore sustainable models of care, including the expanded use of telehealth and regional outreach services, as strategies to reduce carbon emissions and improve healthcare accessibility.
- 16 September 2025
- Published by CSIRO Publishing in Australian Health Review
- Vol. 49 (5)
Environmental impact of travel to neurosurgery outpatient appointments in South Australia
Objective: Outpatient attendance at metropolitan neurosurgical clinics imposes significant logistical and psychosocial burdens on patients, particularly those with central nervous system tumours residing in geographically dispersed regions. In Australia, where vast distances separate many regional populations from tertiary care centres, these burdens may also translate into substantial environmental costs. This study sought to quantify the environmental and economic impact associated with patient travel to public neurosurgery outpatient services in South Australia. Methods: A retrospective analysis was conducted using administrative data from all in-person public neurosurgery outpatient appointments across South Australia’s two public neurosurgical centres between July 2022 and June 2024. Patient postcode data were used to calculate geodesic one-way travel distances to clinic sites. Estimated fuel consumption, carbon dioxide (CO2) emissions, and petrol costs were derived using published national averages for vehicle efficiency and emissions. Analyses were stratified by Modified Monash Model (MMM) classification to assess regional variation. Results: The cohort comprised 9840 patients, accounting for 19,148 outpatient appointments. The median one-way travel distance was 17.7 km (IQR: 9.4–52.1 km), with 16.9% of patients travelling over 100 km. The cumulative distance travelled was 1.75 million km over 2 years, equating to an estimated petrol consumption of 185,531 L and CO2 emissions of 435.6 tonnes. The associated direct fuel cost exceeded AUD 357,000. Although individual environmental impact increased with MMM classification, the highest aggregate emissions were attributable to patients in MMM category 5, reflecting both travel distance and patient volume. Conclusions: The environmental and financial burdens associated with outpatient neurosurgical care are considerable, particularly for patients in rural and remote areas. These findings underscore the need to explore sustainable models of care, including the expanded use of telehealth and regional outreach services, as strategies to reduce carbon emissions and improve healthcare accessibility.
- 3 November 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (1) , 184-186
Assessment of a novel blinding device for nerve catheter studies: a randomised ex vivo study
- 3 November 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (1) , 184-186
Assessment of a novel blinding device for nerve catheter studies: a randomised ex vivo study